Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium - Maintenance

NCT: NCT07684794 · NOT_YET_RECRUITING

NCT IDNCT07684794
StatusNOT_YET_RECRUITING
Start Date2026-08-10
Completion2027-12-31
SponsorMotif Neurotech, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif XCS System when used as indicated for treatment-resistant depression (TRD).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑